Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Receptors, Cell Surface”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Not applicableLooking for participantsNCT06715839
What this trial is testing

Target-specific immunoPET Imaging of Digestive System Carcinoma

Who this might be right for
MalignancyDigestive CancerDigestive System Neoplasm+12 more
RenJi Hospital 400
Testing effectiveness (Phase 2)WithdrawnNCT06703216
What this trial is testing

Pre-emptive Anakinra for Cytokine Event Reduction

Who this might be right for
B-Acute Lymphoblastic LeukemiaCAR-T Cell TherapyCytokine Release Syndrome+2 more
Kevin McNerney
Testing effectiveness (Phase 2)Ended earlyNCT03954106
What this trial is testing

A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity

Who this might be right for
DLBCLNeurotoxicity Syndromes
Jazz Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT04975555
What this trial is testing

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

Who this might be right for
Cytokine Release SyndromeICANSLymphoma, Non-Hodgkin+2 more
University of Alabama at Birmingham 20
Post-approval studies (Phase 4)Study completedNCT01821547
What this trial is testing

New Methods to Measure the Immune Response to Hepatitis B Vaccine

Who this might be right for
Hepatitis B
University of Oxford 21
Testing effectiveness (Phase 2)WithdrawnNCT04102436
What this trial is testing

Non-Viral TCR Gene Therapy

Who this might be right for
Endocrine/NeuroendocrineNon-Small Cell Lung CancerBreast Cancer+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Not Yet RecruitingNCT07166549
What this trial is testing

Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

Who this might be right for
B Cell MalignanciesB-cell LeukemiaB Cell Lymphoma+2 more
University Hospital, Basel, Switzerland 12
Testing effectiveness (Phase 2)Looking for participantsNCT06895473
What this trial is testing

Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
OHSU Knight Cancer Institute 26
Testing effectiveness (Phase 2)Ended earlyNCT05194735
What this trial is testing

Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors

Who this might be right for
Gynecologic CancerColorectal CancerPancreatic Cancer+9 more
Alaunos Therapeutics 8
Not applicableAvailableNCT07614048
What this trial is testing

Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS

Who this might be right for
PDAC - Pancreatic Ductal AdenocarcinomaColorectal Cancer
Providence Health & Services
Not applicableLooking for participantsNCT06031714
What this trial is testing

Fetal Cell Receptors Repertoire

Who this might be right for
Venous UlcerSickle Cell UlcerDiabetic Ulcer+2 more
Assistance Publique - Hôpitaux de Paris 160
Not applicableLooking for participantsNCT04665388
What this trial is testing

LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers

Who this might be right for
Solid Tumor
University Health Network, Toronto 105
Testing effectiveness (Phase 2)Study completedNCT02283658
What this trial is testing

Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Ovarian Endometrioid AdenocarcinomaOvarian Seromucinous CarcinomaOvarian Serous Cystadenocarcinoma+6 more
Mayo Clinic 20
Not applicableStudy completedNCT05292859
What this trial is testing

Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs

Who this might be right for
Gynecologic CancerColorectal CancerPancreatic Cancer+7 more
Alaunos Therapeutics 7
Testing effectiveness (Phase 2)Looking for participantsNCT03412877
What this trial is testing

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

Who this might be right for
Endocrine TumorsNon-Small Cell Lung CancerOvarian Cancer+4 more
National Cancer Institute (NCI) 285
Early research (Phase 1)Looking for participantsNCT06043713
What this trial is testing

Autologous CD8+ and CD4+ Transgenic T Cells Expressing High Affinity KRASG12V Mutation-Specific T Cell Receptors (FH-A11KRASG12V-TCR) in Treating Patients With Metastatic Solid Tumor Cancers With KRAS G12V Mutations

Who this might be right for
Metastatic Malignant Solid Neoplasm
Fred Hutchinson Cancer Center 24
Not applicableStudy completedNCT00003763
What this trial is testing

Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer

Who this might be right for
Ovarian Cancer
Endocyte 35
Not applicableStudy completedNCT06686602
What this trial is testing

A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast Cancer

Who this might be right for
Advanced/Metastatic NSCLCAdvanced/Metastatic HER2-negative Breast Cancer
Daiichi Sankyo 13,759